Certain sequence variants of the α-synuclein gene are linked to the risk of Parkinson's disease. An analysis of these variants using gene-editing technology provides a possible explanation for this increased risk. See Letter p.95
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Singleton, A. B., Farrer, M. J. & Bonifati, V. Mov. Disord. 28, 14–23 (2013).
Nalls, M. A. et al. Nature Genet. 46, 989–993 (2014).
Soldner, F. et al. Nature 533, 95–99 (2016).
International Parkinson Disease Genomics Consortium. Lancet 377, 641–649 (2011).
Devine, M. J., Gwinn, K., Singleton, A. & Hardy, J. Mov. Disord. 26, 2160–2168 (2011).
Roadmap Epigenomics Consortium. Nature 518, 317–330 (2015).
Heidenreich, M. & Zhang, F. Nature Rev. Neurosci. 17, 36–44 (2016).
Rhinn, H. et al. Nature Commun. 3, 1084 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.A. is a co-founder and consultant for Alector, a biotechnology company. H.R. is a consultant for Alector.
Related links
Rights and permissions
About this article
Cite this article
Abeliovich, A., Rhinn, H. Guilt by genetic association. Nature 533, 40–41 (2016). https://doi.org/10.1038/nature17891
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature17891
This article is cited by
-
Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9
Neuroscience Bulletin (2017)